Irritable Bowel Syndrome Treatment Market 2019 Analysis by Irritable Bowel Syndrome Treatment Market 2019 Analysis by Abbott Laboratories*, Synergy, Sucampo, Valeant, Ardelyx, Astellas Pharma, Novartis, GlaxoSmithKline, Ironwood Pharmaceuticals) Industry

Global Irritable Bowel Syndrome Treatment Market 2019-2025: The global irritable bowel syndrome treatment market was valued at US$ 726.1 million in 2016 and is projected to rise a healthy CAGR of 12.9% over the forecast period (2017-2025).

Get a Quick Free Sample report at https://decisionmarketreports.com/request-sample?productID=981969&utm_source=sd&utm_medium=OpenPR

The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life. However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.

Market Dynamics
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/981969/global-irritable-bowel-syndrome-treatment-market?utm_source=sd&utm_medium=OpenPR

Market Taxonomy
This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.

Key features of the study:
• This report provides in-depth analysis of irritable bowel syndrome treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global irritable bowel syndrome treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories*, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., Ironwood Pharmaceuticals, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the Irritable Bowel Syndrome Treatment Market

For Better Insights help@decisionmarketreports.com

Detailed Segmentation:
Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
• Lubiprostone
• Linaclotide
• Eluxadoline
• Rifaximin
• Ramosetron Hydrochloride
• Others

Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
• IBS-Constipation
• IBS-Diarrhea

Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Irritable Bowel Syndrome Treatment Market, By Geography:
• Worldwide
Company Profiles
• Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

• Synergy Pharmaceuticals, Inc.
• Sucampo Pharmaceuticals, Inc.
• Valeant Pharmaceuticals International, Inc.
• Ardelyx, Inc.
• Astellas Pharma Inc.
• Novartis AG
• GlaxoSmithKline plc.
• Ironwood Pharmaceuticals, Inc.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet By Drug Type
 Market Snippet By Medical Condition
 Market Snippet By Distribution Channel
 Market Snippet By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Consumer Trends
o Impact Analysis
o FDA Approval Timeline
o PEST Analysis
o Probiotics & Prebiotics

4. Global Irritable Bowel Syndrome Treatment Market, By Drug Type, 2017 - 2025 (US$ Mn)
o Introduction
 Market Share Analysis, 2016 and 2025 (%)
 Y-o-Y Growth Analysis, 2017 - 2025
 Segment Trends
o Lubiprostone
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Linaclotide
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Eluxadoline
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Rifaximin
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Ramosetron Hydrochloride
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)

5. Global Irritable Bowel Syndrome Treatment Market, By Medical Condition, 2017 - 2025 (US$ Mn)
o Introduction
 Market Share Analysis, 2016 and 2025 (%)
 Y-o-Y Growth Analysis, 2017 - 2025
 Segment Trends
o IBS - Constipation
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o IBS - Diarrhea
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)

6. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2017 - 2025 (US$ Mn)

…Continued

Request a In-depth Insights PDF Sample Brochure at https://decisionmarketreports.com/request-sample?productID=981969&utm_source=sd&utm_medium=OpenPR

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com
Get the latest updates on LinkedIn: https://www.linkedin.com/company/decisionmarketreports/

This release was published on openPR.